Ekso Bionics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $3,140 | $4,227 | $2,057 | $3,375 |
Gross Profit | 1,671 | 2,549 | 819 | 1,806 |
EBITDA | -3,759 | -1,036 | -2,267 | -3,440 |
EBIT | -4,210 | -1,403 | -2,644 | -2,963 |
Net Income | -4,674 | -1,421 | -2,709 | -2,891 |
Net Change In Cash | 3,140 | 4,227 | 2,057 | 3,375 |
Free Cash Flow | -4,381 | -2,011 | -3,444 | -1,965 |
Cash | 1,169 | 2,722 | 5,242 | 8,054 |
Basic Shares | 2,426 | 2,616 | 2,180 | 25,393 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $12,799 | $17,925 | $18,279 | $12,912 |
Gross Profit | 6,845 | 9,511 | 9,079 | 6,214 |
EBITDA | -9,813 | -9,453 | -13,198 | -14,037 |
EBIT | -11,386 | -11,061 | -14,896 | -14,924 |
Net Income | -11,695 | -11,330 | -15,198 | -15,080 |
Net Change In Cash | 12,799 | 17,925 | 18,279 | 12,912 |
Free Cash Flow | -11,989 | -9,883 | -12,211 | -14,882 |
Cash | 1,169 | 6,493 | 8,638 | 20,525 |
Basic Shares | 2,426 | 20,161 | 13,867 | 12,962 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.46 |
2025-09-30 | -$0.54 |
2025-06-30 | -$1.24 |
2025-03-31 | -$0.12 |
